BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boudoulas KD, Triposkiadis F, Parissis J, Butler J, Boudoulas H. The Cardio-Renal Interrelationship. Progress in Cardiovascular Diseases 2017;59:636-48. [DOI: 10.1016/j.pcad.2016.12.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Toba H, Lindsey ML. Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly. Pharmacol Ther 2019;193:99-120. [PMID: 30149103 DOI: 10.1016/j.pharmthera.2018.08.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
2 Tutakhel OAZ, Bianchi F, Smits DA, Bindels RJM, Hoenderop JGJ, van der Wijst J. Dominant functional role of the novel phosphorylation site S811 in the human renal NaCl cotransporter. FASEB J 2018;32:4482-93. [PMID: 29547703 DOI: 10.1096/fj.201701047R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Song H, Hu H, Liao D, Wei J, Wei C, Liao F, Zhou W, Mo Z, Jiang S, Ruan X, He Y. Left ventricular hypertrophy predicts the decline of glomerular filtration rate in patients with type 2 diabetes mellitus. Int Urol Nephrol 2018;50:2049-59. [DOI: 10.1007/s11255-018-1942-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Cappetta D, Ciuffreda LP, Cozzolino A, Esposito G, Scavone C, Sapio L, Naviglio S, D'Amario D, Crea F, Rossi F, Berrino L, De Angelis A, Urbanek K. Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension. Oxid Med Cell Longev 2019;2019:8912768. [PMID: 30774748 DOI: 10.1155/2019/8912768] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
5 Petra E, Zoidakis J, Vlahou A. Protein biomarkers for cardiorenal syndrome. Expert Rev Proteomics 2019;16:325-36. [PMID: 30855192 DOI: 10.1080/14789450.2019.1592682] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Ramos CSCB, Silva VAPD, Corrêa LBNS, Abboud RS, Boaventura GT, Chagas MA. Long-Term Alpha-Lipoic Acid (ALA) Antioxidant Therapy Reduces Damage in the Cardiovascular System of Streptozotocin-Induced Diabetic Rats. J Diet Suppl 2021;:1-15. [PMID: 34806528 DOI: 10.1080/19390211.2021.2004290] [Reference Citation Analysis]
7 Han X, Ross J, Kolumam G, Pi M, Sonoda J, King G, Quarles LD. Cardiovascular Effects of Renal Distal Tubule Deletion of the FGF Receptor 1 Gene. J Am Soc Nephrol 2018;29:69-80. [PMID: 28993502 DOI: 10.1681/ASN.2017040412] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
8 Carrero JJ, Trevisan M, Evans M, Svennberg E, Szummer K. Kidney function and the risk of heart failure in patients with new-onset atrial fibrillation. International Journal of Cardiology 2020;320:101-5. [DOI: 10.1016/j.ijcard.2020.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Laferriere NR, Kurata WE, Grayson CT, Stecklow KM, Pierce LM. Inhibition of microRNA-124-3p as a novel therapeutic strategy for the treatment of Gulf War Illness: Evaluation in a rat model. Neurotoxicology. 2019;71:16-30. [PMID: 30503814 DOI: 10.1016/j.neuro.2018.11.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Feng J, Li H, Li J, Meng P, Wang L, Liu C, Zhao S, Sun W, Zhang Y. hnRNPK knockdown alleviates NLRP3 inflammasome priming by repressing FLIP expression in Raw264.7 macrophages. Redox Rep 2020;25:104-11. [PMID: 33269646 DOI: 10.1080/13510002.2020.1857157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Gabbin B, Meraviglia V, Mummery CL, Rabelink TJ, van Meer BJ, van den Berg CW, Bellin M. Toward Human Models of Cardiorenal Syndrome in vitro. Front Cardiovasc Med 2022;9:889553. [DOI: 10.3389/fcvm.2022.889553] [Reference Citation Analysis]
12 Nascimento M, Punaro GR, Serralha RS, Lima DY, Mouro MG, Oliveira LCG, Casarini DE, Rodrigues AM, Higa EMS. Inhibition of the P2X7 receptor improves renal function via renin-angiotensin system and nitric oxide on diabetic nephropathy in rats. Life Sci 2020;251:117640. [PMID: 32259603 DOI: 10.1016/j.lfs.2020.117640] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Triposkiadis F, Xanthopoulos A, Parissis J, Butler J, Farmakis D. Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers. Heart Fail Rev. [DOI: 10.1007/s10741-020-09987-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Boudoulas KD, Triposkiadis F, Stefanadis C, Boudoulas H. Aortic Size and Aortic Dissection: Does One Size Fit All? Cardiology 2018;139:147-50. [PMID: 29346797 DOI: 10.1159/000484040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Noguchi K, Ishida J, Kim JD, Muromachi N, Kako K, Mizukami H, Lu W, Ishimaru T, Kawasaki S, Kaneko S, Usui J, Ohtsu H, Yamagata K, Fukamizu A. Histamine receptor agonist alleviates severe cardiorenal damages by eliciting anti-inflammatory programming. Proc Natl Acad Sci U S A 2020;117:3150-6. [PMID: 31992639 DOI: 10.1073/pnas.1909124117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Ernsberger U, Rohrer H. Sympathetic tales: subdivisons of the autonomic nervous system and the impact of developmental studies. Neural Dev 2018;13:20. [PMID: 30213267 DOI: 10.1186/s13064-018-0117-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
17 Tanaka M, Yamakage H, Inoue T, Odori S, Kusakabe T, Shimatsu A, Satoh-Asahara N. Beneficial Effects of Ipragliflozin on the Renal Function and Serum Uric Acid Levels in Japanese Patients with Type 2 Diabetes: A Randomized, 12-week, Open-label, Active-controlled Trial. Intern Med 2020;59:601-9. [PMID: 32115517 DOI: 10.2169/internalmedicine.3473-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Carubelli V, Metra M, Lund LH. Negotiating renal dysfunction when treating patients with heart failure. Expert Rev Cardiovasc Ther 2018;16:113-22. [PMID: 29292652 DOI: 10.1080/14779072.2018.1422178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Moriano-Gutierrez S, Koch EJ, Bussan H, Romano K, Belcaid M, Rey FE, Ruby EG, McFall-Ngai MJ. Critical symbiont signals drive both local and systemic changes in diel and developmental host gene expression. Proc Natl Acad Sci U S A 2019;116:7990-9. [PMID: 30833394 DOI: 10.1073/pnas.1819897116] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
20 Kereliuk SM, Brawerman GM, Dolinsky VW. Maternal Macronutrient Consumption and the Developmental Origins of Metabolic Disease in the Offspring. Int J Mol Sci 2017;18:E1451. [PMID: 28684678 DOI: 10.3390/ijms18071451] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
21 Duraes AR, da Silva WAP, Filho CRH, de Souza Lima Bitar Y, Neto MG. Heart Failure and Comorbidities—Part 2. Curr Emerg Hosp Med Rep 2020;8:69-75. [DOI: 10.1007/s40138-020-00211-8] [Reference Citation Analysis]
22 Bailey CJ, Day C, Bellary S. Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease. Curr Diab Rep 2022. [PMID: 35113333 DOI: 10.1007/s11892-021-01442-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]